Pharma faces a projected $23B profitability shortfall in five years and $10B less revenue from launches due to COVID-19, making efficiency critical. IQVIA highlights the need for optimized operations, targeted HCP engagement, and compliance. With 340+ products forecasted for launch by 2028, success depends on digital tactics, data-driven targeting, and global scalability. Tools like OCE, used in 100+ countries, and the OneKey database of 21.5M HCPs and 2.5M HCOs enable precise outreach. IQVIA manages 100K+ meetings and $300M+ transactions annually, helping clients reduce SG&A costs, ensure compliance, and orchestrate launches effectively.

Join for free to read